Gemina Laboratories Ltd.
GLAB
Rang in Aktien
#35673
Gemina Laboratories Ltd. is a Canadian biotechnology company dedicated to the... Gemina Laboratories Ltd. is a Canadian biotechnology company dedicated to the research, development, and commercialization of in-vitro diagnostics. The firm invents innovative surface functionalization chemistries for identifying pathogens and biomarkers. Among its current projects, Gemina is advancing the POC Antigen COVID test, a rapid, point-of-care lateral flow assay strip specifically designed to detect active COVID-19 infections. The company maintains its headquarters in Vancouver, Canada.
Aktienkurs
$0.04377166
Zuletzt synchronisiert: 2026-02-05
Marktkapitalisierung
$3.35M
Veränderung (1 Tag)
-0.30%
Veränderung (1 Jahr)
-81.04%
Land
CA
Handel Gemina Laboratories Ltd. (GLAB)
Kategorie
Healthcare
Kursverlauf für Gemina Laboratories Ltd. (GLAB)
Höchster Schlusskurs: $0.05 am 2026-10-01
Niedrigster Schlusskurs: $0.42 am 2022-03-01
Niedrigster Schlusskurs: $0.42 am 2022-03-01
Kursverlauf der Aktie von Gemina Laboratories Ltd. von 2022 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | -16.83% |
| 2025 | -80.23% |
| 2024 | 53.58% |
| 2023 | 50.57% |
| 2022 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $527.18 | 23.67% |
US
|
|
| $251.29 | 814.11% |
US
|
|
| $138.33 | -3.31% |
AU
|
|
| $890.85 | 6.72% |
NL
|
|
| $752.87 | 7.40% |
CH
|
